Synjardy XR 25 mg/1 (Empagliflozin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 25 mg/1

Synjardy XR 25 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to support blood sugar management in adults with type 2 diabetes. This medication is taken orally and is available in a 30-tablet bottle.

Strength

25 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-88)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy XR 25 mg/1 is primarily used to help manage blood sugar levels in adults with type 2 diabetes. The combination of empagliflozin and metformin hydrochloride works to improve glycemic control. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. People often ask, 'What is Synjardy XR used for?' and the answer is that it is designed to assist in maintaining stable blood sugar levels.

Side Effects

Common effects of Synjardy XR 25 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or low blood sugar levels. These effects can vary from person to person and may subside over time as the body adjusts to the medication.

Precautions & Warnings

Synjardy XR 25 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Synjardy XR 25 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. It is important to discuss all current medications with a healthcare provider before starting Synjardy XR. Alcohol consumption should be limited, as it can increase the risk of low blood sugar levels. Additionally, certain dietary supplements and over-the-counter medications may also interact with Synjardy XR.

Frequently Asked Questions

Synjardy XR 25 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes.

Synjardy XR 25 mg/1 should be taken orally, typically once daily, with a meal to minimize gastrointestinal side effects.

Common side effects may include nausea, diarrhea, and urinary tract infections.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Synjardy XR 25 mg/1 should be stored at room temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.